ACM
GH icon

Adalta Capital Management’s Guardant Health GH Stock Holding History

Adalta Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.68M Sell
61,473
-1,815
-3% -$182K 2.72% 12
2025
Q4 		$6.46M Hold
63,288
– – 2.89% 12
2025
Q3 		$3.95M Sell
63,288
-75
-0.1% -$4.08K 1.8% 16
2025
Q2 		$3.3M Sell
63,363
-300
-0.5% -$13.4K 1.65% 16
2025
Q1 		$2.71M Sell
63,663
-4,600
-7% -$198K 1.44% 19
2024
Q4 		$2.09M Sell
68,263
-2,700
-4% -$76K 1.09% 21
2024
Q3 		$1.63M Sell
70,963
-60
-0.1% -$1.7K 0.84% 26
2024
Q2 		$2.05M Hold
71,023
– – 1.12% 19
2024
Q1 		$1.47M Buy
71,023
+9,565
+16% +$205K 0.81% 26
2023
Q4 		$1.66M Sell
61,458
-19,762
-24% -$518K 1.01% 24
2023
Q3 		$2.41M Buy
81,220
+45
+0.1% +$1.58K 1.64% 16
2023
Q2 		$2.91M Sell
81,175
-700
-0.9% -$20.1K 1.94% 15
2023
Q1 		$1.92M Sell
81,875
-1,890
-2% -$54K 1.34% 20
2022
Q4 		$2.28M Sell
83,765
-18,635
-18% -$853K 1.61% 18
2022
Q3 		$5.51M Sell
102,400
-1,920
-2% -$98.6K 3.96% 9
2022
Q2 		$4.21M Sell
104,320
-2,500
-2% -$124K 2.73% 12
2022
Q1 		$7.08M Sell
106,820
-3,440
-3% -$235K 3.53% 10
2021
Q4 		$11M Buy
110,260
+3,350
+3% +$346K 5.09% 6
2021
Q3 		$13.4M Sell
106,910
-418
-0.4% -$49.7K 7.4% 2
2021
Q2 		$13.3M Buy
107,328
+183
+0.2% +$24.6K 7.26% 2
2021
Q1 		$16.4M Sell
107,145
-1,300
-1% -$196K 9.44% 2
2020
Q4 		$14M Sell
108,445
-60
-0.1% -$6.9K 8.82% 2
2020
Q3 		$12.1M Buy
108,505
+150
+0.1% +$13.7K 8.85% 2
2020
Q2 		$8.79M Sell
108,355
-2,755
-2% -$222K 7% 2
2020
Q1 		$7.73M Sell
111,110
-3,625
-3% -$278K 7.02% 2
2019
Q4 		$8.97M Buy
114,735
+2,320
+2% +$167K 5.64% 3
2019
Q3 		$7.17M Sell
112,415
-925
-0.8% -$81.5K 4.75% 3
2019
Q2 		$9.78M Buy
+113,340
New +$8.66M 6.43% 2

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adalta Capital Management's GH Position: Q1 2026 in Review

Adalta Capital Management reduced its Guardant Health (GH) stake by 2.9% in Q1 2026, selling an estimated $182K and leaving 61,473 shares worth $5.68M. The position accounts for 2.72% of the portfolio, ranked #12.

Adalta Capital Management first reported a position in GH in Q2 2019 and has held it in 28 quarters since. The position peaked at $16.4M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Adalta Capital Management held 61,473 shares of Guardant Health worth $5.68M as of Q1 2026.
  • Adalta Capital Management sold 1,815 Guardant Health shares in Q1 2026, an estimated $182K.
  • Guardant Health made up 2.72% of Adalta Capital Management's portfolio in Q1 2026, its #12 holding.
  • Adalta Capital Management first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
  • Adalta Capital Management's Guardant Health position peaked at $16.4M in Q1 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Adalta Capital Management's 13F filing for Q1 2026, filed 18 May 2026.